<DOC>
	<DOCNO>NCT02628652</DOCNO>
	<brief_summary>The primary objective study determine tolerability two polyglycan food ingredient , GOS GLOS , two different level healthy human subject . The comparator study Inulin FOS , commercially available glycan supplement .</brief_summary>
	<brief_title>Study Evaluate Tolerability Prebiotics Microbiota</brief_title>
	<detailed_description />
	<criteria>1 . Be able give write informed consent , 2 . Be male female , 18 40 year age , 3 . Have BMI ≥ 20 &amp; ≤ 27 kg/m2 , 4 . Be nonpregnant female , 5 . Be generally good health , 6 . Subjects continue his/her normal diet exercise routine , 7 . Be Irish National . 1 . Are less 18 great 40 year age , 2 . Females pregnant , lactate wish become pregnant study . Female subject currently either : nonchildbearing potential ( i.e. , physiologically incapable become pregnant , include female postmenopausal female surgically sterilize ( via document hysterectomy bilateral tubal ligation ) . ( For purpose study , postmenopausal define one year without menses ) , OR child bear potential , subject eligible enter participate study lactate negative urine pregnancy test screen visit , visit 2 upon completion study visit 7 . The subject must also agree one follow method contraception : . Complete abstinence intercourse two week prior administration study , throughout clinical trial , completion followup procedure two week follow discontinuation study medication case subject discontinues study prematurely . ( Subjects utilize method must agree use alternate method contraception become sexually active query whether abstinent precede 2 week present clinic Final Visit . ) , ii . male sexual partner surgically sterilize prior Screen Visit male sexual partner subject , iii . sexual partner ( ) gender , iv . Oral implant contraceptive ( either combine progestogen ) doublebarrier method contraception consist spermicide either condom diaphragm . ( Women childbearing potential use oral contraceptive combination doublebarrier method contraception require continue use form contraception 1 week follow discontinuation study medication ) , v. Use doublebarrier contraception , specifically , spermicide plus mechanical barrier ( e.g . male condom , female diaphragm ) . The subject must use method least 1 week follow end study , vi . Use intrauterine device ( IUD ) publish data show high expected failure rate le 1 % per year . The subject must device insert least 2 week prior first Screen Visit , throughout study , 2 week follow end study . 3 . Are hypersensitive component test product , 4 . Are currently take probiotic prebiotic supplement , take past 28 day , 5 . Unwilling avoid probiotics/prebiotics supplement duration study 6 . Subject take antibiotic previous 3 month , 7 . Have significant acute chronic , unstable untreated disease condition contraindicates , investigator judgement , entry study , 8 . Subject smoker , 9 . Subject history drug and/or alcohol abuse time enrolment , 10 . Having condition take medication investigator believe would interfere objective study , pose safety risk confound interpretation study result ; 11 . Individuals , opinion investigator , consider poor attendee unlikely reason able comply trial , 12 . Subjects may receive treatment involve experimental drug , 13 . If subject recent experimental trial , must complete less 60 day prior study , 14 . Have malignant disease concomitant endstage organ disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Microbiome</keyword>
	<keyword>FOS</keyword>
	<keyword>polyglycan</keyword>
	<keyword>prebiotic</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>